Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19
GW Stone, ME Farkouh, A Lala, E Tinuoye… - Journal of the American …, 2023 - jacc.org
Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …
have reported conflicting results. Objectives We sought to determine the safety and …
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
GW STONE, ME FARKOUH, A LALA… - Journal of the …, 2023 - observatorio.fm.usp.br
BACKGROUND Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. OBJECTIVES We sought to determine the safety and …
have reported conflicting results. OBJECTIVES We sought to determine the safety and …
[HTML][HTML] Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
GW Stone, ME Farkouh, A Lala, E Tinuoye… - Journal of the …, 2023 - ncbi.nlm.nih.gov
Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …
have reported conflicting results. Objectives We sought to determine the safety and …
Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19.
GW Stone, ME Farkouh, A Lala, E Tinuoye, O Dressler… - 2023 - cabidigitallibrary.org
Background: Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives: We sought to determine the safety and …
have reported conflicting results. Objectives: We sought to determine the safety and …
[HTML][HTML] Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
GW Stone, ME Farkouh, A Lala, E Tinuoye… - Journal of the American …, 2023 - Elsevier
Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …
have reported conflicting results. Objectives We sought to determine the safety and …
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
GW Stone, ME Farkouh, A Lala, E Tinuoye, O Dressler… - 2023 - pubmed.ncbi.nlm.nih.gov
Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …
have reported conflicting results. Objectives We sought to determine the safety and …
Anticoagulation Strategies in Non-Critically Ill Patients Hospitalized with COVID-19: A Randomized Clinical Trial
G Stone, M Farkouh, A Lala, E Tinuoye… - Journal of the …, 2023 - europepmc.org
Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …
have reported conflicting results. Objectives We sought to determine the safety and …
Anticoagulation Strategies in Non-Critically Ill Patients Hospitalized with COVID-19: A Randomized Clinical Trial.
GW Stone, ME Farkouh, A Lala, E Tinuoye… - Journal of the …, 2023 - europepmc.org
Prior studies of therapeutic-dose anticoagulation in patients with COVID-19 have reported
conflicting results. We sought to determine the safety and effectiveness of therapeutic-dose …
conflicting results. We sought to determine the safety and effectiveness of therapeutic-dose …